CN Patent

CN113164452A — 治疗老花眼、散瞳和其他眼部疾病的方法和组合物

Assigned to Okufield Pharmaceutical Co ltd · Expires 2021-07-23 · 5y expired

What this patent protects

本发明提供了包含α‑肾上腺素能拮抗剂例如酚妥拉明的方法、组合物和试剂盒，用于单一疗法中或作为联合疗法的一部分，以治疗患有老花眼、散瞳和/或其他眼部疾病的患者。

USPTO Abstract

本发明提供了包含α‑肾上腺素能拮抗剂例如酚妥拉明的方法、组合物和试剂盒，用于单一疗法中或作为联合疗法的一部分，以治疗患有老花眼、散瞳和/或其他眼部疾病的患者。

Drugs covered by this patent

phentolamine-mesylate (PHENTOLAMINE MESYLATE)

Patent Metadata

Patent number: CN113164452A
Jurisdiction: CN
Classification: —
Expires: 2021-07-23
Drug substance claim: No
Drug product claim: No
Assignee: Okufield Pharmaceutical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.